The HEMEX team participated in a workshop organized by AMT Medical at the UMC Utrecht (Netherlands) in the first week of December. A team of world-renowned cardiac surgeons demonstrated the application of AMT’s ELANA (Excimer Laser Assisted Non-occlusive Anastomosis) Heart Bypass System on a beating porcine heart on LifeTec’s innovative cardiac simulator platform.
The ELANA Heart Bypass System is a uniquely designed surgical device, that connects a donor bypass vessel with a recipient coronary artery in a simplified procedure on a beating heart, without the need for arresting blood flow or complex hand suturing.
The SAFE-CAB clinical trial is designed to demonstrate safety and efficacy of minimally invasive CABG surgeries using the ELANA technique, in order to establish it as the new golden standard to obtain standardized, reproducible anastomosis and thus substantially improve patient outcomes and reduce health care costs.
Co-funded by the Horizon 2020 Framework Programme of the European Union and the Grant Agreement (GA) No. 869922.